10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2014 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 19, 2015) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Revenues: | |||
| Product sales | $ 19,327 | 18,192 | 16,639 |
| Other revenues | 736 | 484 | 626 |
| Total revenues | 20,063 | 18,676 | 17,265 |
| Operating expenses: | |||
| Cost of sales | 4,422 | 3,346 | 3,199 |
| Research and development | 4,297 | 4,083 | 3,380 |
| Selling, general and administrative | 4,699 | 5,184 | 4,814 |
| Other | 454 | 196 | 295 |
| Total operating expenses | 13,872 | 12,809 | 11,688 |
| Operating income | 6,191 | 5,867 | 5,577 |
| Interest expense, net | 1,071 | 1,022 | 1,053 |
| Interest and other income, net | 465 | 420 | 485 |
| Income before income taxes | 5,585 | 5,265 | 5,009 |
| Provision for income taxes | 427 | 184 | 664 |
| Net income | 5,158 | 5,081 | 4,345 |
| Earnings per share: | |||
| Basic (in usd per share) | 6.80 | 6.75 | 5.61 |
| Diluted (in usd per share) | 6.70 | 6.64 | 5.52 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 759 | 753 | 775 |
| Diluted (in shares) | 770 | 765 | 787 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2014 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 19, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Net income | $ 5,158 | 5,081 | 4,345 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| Foreign currency translation losses | (196) | (80) | (9) |
| Effective portion of cash flow hedges | 323 | 2 | (78) |
| Net unrealized gains (losses) on available-for-sale securities | 24 | (226) | 63 |
| Other | 2 | (3) | (1) |
| Other comprehensive income (loss), net of tax | 153 | (307) | (25) |
| Comprehensive income | 5,311 | 4,774 | 4,320 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 19, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Cash flows from operating activities: | |||
| Net income | $ 5,158 | 5,081 | 4,345 |
| Depreciation and amortization | 2,092 | 1,286 | 1,088 |
| Stock-based compensation expense | 408 | 403 | 362 |
| Deferred income taxes | (108) | (189) | 28 |
| Property, plant and equipment impairments | 97 | 19 | 178 |
| Other items, net | (213) | 84 | (74) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | 136 | (38) | 348 |
| Inventories | 327 | (7) | (150) |
| Other assets | (1) | (59) | 124 |
| Accounts payable | 405 | (184) | 161 |
| Accrued income taxes | (103) | (326) | 87 |
| Legal reserve | 0 | 0 | (780) |
| Other liabilities | 357 | 221 | 165 |
| Net cash provided by operating activities | 8,555 | 6,291 | 5,882 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (718) | (693) | (689) |
| Cash paid for acquisitions, net of cash acquired | (165) | (9,434) | (2,390) |
| Purchases of intangible assets | (285) | 0 | (25) |
| Purchases of marketable securities | (25,878) | (21,965) | (26,241) |
| Proceeds from sales of marketable securities | 16,697 | 19,123 | 17,372 |
| Proceeds from maturities of marketable securities | 4,199 | 5,090 | 1,994 |
| Change in restricted investments, net | 533 | (520) | 0 |
| Other | (135) | (70) | (11) |
| Net cash used in investing activities | (5,752) | (8,469) | (9,990) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,476 | 8,054 | 4,933 |
| Repayment of debt | (5,605) | (3,371) | (123) |
| Repurchases of common stock | (138) | (832) | (4,607) |
| Dividends paid | (1,851) | (1,415) | (1,118) |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 186 | 296 | 1,288 |
| Other | 55 | (6) | 46 |
| Net cash (used in) provided by financing activities | (2,877) | 2,726 | 419 |
| (Decrease) increase in cash and cash equivalents | (74) | 548 | (3,689) |
| Cash and cash equivalents at beginning of period | 3,805 | 3,257 | |
| Cash and cash equivalents at end of period | 3,731 | 3,805 | 3,257 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2014 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2014 10-K (Filed: Feb 19, 2015) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2014 | Dec 31, 2013 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,731 | 3,805 |
| Marketable securities | 23,295 | 15,596 |
| Trade receivables, net | 2,546 | 2,697 |
| Inventories | 2,647 | 3,019 |
| Other current assets | 2,494 | 2,250 |
| Total current assets | 34,713 | 27,367 |
| Property, plant and equipment, net | 5,223 | 5,349 |
| Intangible assets, net | 12,693 | 13,262 |
| Goodwill | 14,788 | 14,968 |
| Restricted investments | 0 | 3,412 |
| Other assets | 1,592 | 1,767 |
| Total assets | 69,009 | 66,125 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,212 | 787 |
| Accrued liabilities | 5,296 | 4,655 |
| Current portion of long-term debt | 500 | 2,505 |
| Total current liabilities | 7,008 | 7,947 |
| Long-term debt | 30,215 | 29,623 |
| Long-term deferred tax liability | 3,461 | 3,498 |
| Other noncurrent liabilities | 2,547 | 2,961 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding 760.4 shares in 2014 and 754.6 shares in 2013 | 30,410 | 29,891 |
| Accumulated deficit | (4,624) | (7,634) |
| Accumulated other comprehensive loss | (8) | (161) |
| Total stockholders equity | 25,778 | 22,096 |
| Total liabilities and stockholders equity | 69,009 | 66,125 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |